Broen JCA - Search Results

1

The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: A narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines.

Deijns SJ, Broen JCA, Kruyt ND, Schubart CD, Andreoli L, Tincani A, Limper M. Deijns SJ, et al. Among authors: broen jca. Autoimmun Rev. 2020 Aug;19(8):102592. doi: 10.1016/j.autrev.2020.102592. Epub 2020 Jun 17. Autoimmun Rev. 2020. PMID: 32561462 Free article. Review.

2

Unraveling IFN-I response dynamics and TNF crosstalk in the pathophysiology of systemic lupus erythematosus.

Van Eyndhoven LC, Chouri E, Matos CI, Pandit A, Radstake TRDJ, Broen JCA, Singh A, Tel J. Van Eyndhoven LC, et al. Among authors: broen jca. Front Immunol. 2024 Mar 26;15:1322814. doi: 10.3389/fimmu.2024.1322814. eCollection 2024. Front Immunol. 2024. PMID: 38596672 Free PMC article.

3

The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.

Broen JC, Radstake TR, Rossato M. Broen JC, et al. Nat Rev Rheumatol. 2014 Nov;10(11):671-81. doi: 10.1038/nrrheum.2014.128. Epub 2014 Aug 19. Nat Rev Rheumatol. 2014. PMID: 25136786 Review.

4

B-cells and schizophrenia: A promising link or a finding lost in translation?

van Mierlo HC, Broen JCA, Kahn RS, de Witte LD. van Mierlo HC, et al. Among authors: broen jca. Brain Behav Immun. 2019 Oct;81:52-62. doi: 10.1016/j.bbi.2019.06.043. Epub 2019 Jul 2. Brain Behav Immun. 2019. PMID: 31271869 Review.

5

Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology.

Broen JCA, van Laar JM. Broen JCA, et al. Nat Rev Rheumatol. 2020 Mar;16(3):167-178. doi: 10.1038/s41584-020-0374-8. Epub 2020 Feb 13. Nat Rev Rheumatol. 2020. PMID: 32055040 Review.

6

Genetics of systemic sclerosis: an update.

Broen JC, Coenen MJ, Radstake TR. Broen JC, et al. Curr Rheumatol Rep. 2012 Feb;14(1):11-21. doi: 10.1007/s11926-011-0221-7. Curr Rheumatol Rep. 2012. PMID: 22102179 Free PMC article. Review.

7

Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?

Blokland SLM, Hillen MR, Wichers CGK, Zimmermann M, Kruize AA, Radstake TRDJ, Broen JCA, van Roon JAG. Blokland SLM, et al. Among authors: broen jca. RMD Open. 2019 Jan 11;5(1):e000701. doi: 10.1136/rmdopen-2018-000701. eCollection 2019. RMD Open. 2019. PMID: 30713717 Free PMC article. No abstract available.

8

Deciphering the genetic background of systemic sclerosis.

Broen JC, Coenen MJ, Radstake TR. Broen JC, et al. Expert Rev Clin Immunol. 2011 Jul;7(4):449-62. doi: 10.1586/eci.11.26. Expert Rev Clin Immunol. 2011. PMID: 21790288 Review.

9

The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes.

Radstake TR, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, Deng Y, Simms R, Lubberts E, Lafyatis R. Radstake TR, et al. PLoS One. 2009 Jun 17;4(6):e5903. doi: 10.1371/journal.pone.0005903. PLoS One. 2009. PMID: 19536281 Free PMC article.

10

Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.

Radstake TR, van Bon L, Broen J, Wenink M, Santegoets K, Deng Y, Hussaini A, Simms R, Cruikshank WW, Lafyatis R. Radstake TR, et al. PLoS One. 2009 Jun 22;4(6):e5981. doi: 10.1371/journal.pone.0005981. PLoS One. 2009. PMID: 19543397 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page